PURPOSE: The purpose was to review relevant scientific papers written since 1989 which focused on the prevalence and management of dysgeusia as an oral side effect of cancer treatment. METHODS: Our literature search was limited to English language papers published between 1990 and 2008. A total of 30 papers were reviewed; the results of 26 of these papers were included in the present systematic review. A structured assessment form was used by two reviewers for each paper. Studies were weighted as to the quality of the study design, and treatment recommendations were based on the relative strength of each paper. RESULTS: A wide range in reported prevalence of dysgeusia was identified with the weighted prevalence from 56-76%, depending on the type of cancer treatment. Attempts to prevent dysgeusia through the prophylactic use of zinc sulfate or amifostine have been of limited benefit. Nutritional counseling may be helpful to some patients in minimizing the symptoms of dysgeusia. CONCLUSIONS: Dysgeusia is a common oral side effect of cancer therapy (radiotherapy, chemotherapy, or combined modality therapy) and often impacts negatively on quality of life. From the current literature, there does not appear to be a predictable way of preventing or treating dysgeusia.
PURPOSE: The purpose was to review relevant scientific papers written since 1989 which focused on the prevalence and management of dysgeusia as an oral side effect of cancer treatment. METHODS: Our literature search was limited to English language papers published between 1990 and 2008. A total of 30 papers were reviewed; the results of 26 of these papers were included in the present systematic review. A structured assessment form was used by two reviewers for each paper. Studies were weighted as to the quality of the study design, and treatment recommendations were based on the relative strength of each paper. RESULTS: A wide range in reported prevalence of dysgeusia was identified with the weighted prevalence from 56-76%, depending on the type of cancer treatment. Attempts to prevent dysgeusia through the prophylactic use of zinc sulfate or amifostine have been of limited benefit. Nutritional counseling may be helpful to some patients in minimizing the symptoms of dysgeusia. CONCLUSIONS:Dysgeusia is a common oral side effect of cancer therapy (radiotherapy, chemotherapy, or combined modality therapy) and often impacts negatively on quality of life. From the current literature, there does not appear to be a predictable way of preventing or treating dysgeusia.
Authors: M Martín; A Lluch; M A Seguí; A Ruiz; M Ramos; E Adrover; A Rodríguez-Lescure; R Grosse; L Calvo; C Fernandez-Chacón; M Roset; A Antón; D Isla; P Martínez del Prado; L Iglesias; J Zaluski; A Arcusa; J M López-Vega; M Muñoz; J R Mel Journal: Ann Oncol Date: 2006-06-09 Impact factor: 32.976
Authors: C Van Poznak; A D Seidman; M M Reidenberg; M M Moasser; N Sklarin; K Van Zee; P Borgen; M Gollub; D Bacotti; T J Yao; R Bloch; M Ligueros; M Sonenberg; L Norton; C Hudis Journal: Breast Cancer Res Treat Date: 2001-04 Impact factor: 4.872
Authors: Phillip G Febbo; Jerome P Richie; Daniel J George; Massimo Loda; Judith Manola; Sridhar Shankar; Agnieska Szot Barnes; Clare Tempany; William Catalona; Philip W Kantoff; William K Oh Journal: Clin Cancer Res Date: 2005-07-15 Impact factor: 12.531
Authors: Chad M Amosson; Bin S Teh; T John Van; Nathan Uy; Eugene Huang; Wei-Yuan Mai; Anna Frolov; Shiao Y Woo; J Kam Chiu; L Steven Carpenter; Hsin H Lu; Walter H Grant; E Brian Butler Journal: Int J Radiat Oncol Biol Phys Date: 2003-05-01 Impact factor: 7.038
Authors: Roberto Maisano; Marzia Mare; Maria Zavettieri; Nicola Caristi; Mario Mesiti; Claudio Scisca; Francesco La Torre Journal: Anticancer Res Date: 2003 Mar-Apr Impact factor: 2.480
Authors: G Batist; F Patenaude; P Champagne; D Croteau; C Levinton; C Hariton; B Escudier; E Dupont Journal: Ann Oncol Date: 2002-08 Impact factor: 32.976
Authors: G Aprile; F E Pisa; A Follador; L Foltran; F De Pauli; M Mazzer; S Lutrino; C S Sacco; M Mansutti; G Fasola Journal: Support Care Cancer Date: 2012-06-22 Impact factor: 3.603
Authors: M Alvarez-Camacho; S Gonella; S Ghosh; C Kubrak; R A Scrimger; K P Chu; W V Wismer Journal: Qual Life Res Date: 2015-11-20 Impact factor: 4.147
Authors: Mariana Henriques Ferreira; Leticia Mello Bezinelli; Fernanda de Paula Eduardo; Roberta Marques Lopes; Andrea Z Pereira; Nelson Hamerschlack; Luciana Corrêa Journal: Support Care Cancer Date: 2019-06-24 Impact factor: 3.603
Authors: Javier Amézaga; Begoña Alfaro; Yolanda Ríos; Aitziber Larraioz; Gurutze Ugartemendia; Ander Urruticoechea; Itziar Tueros Journal: Support Care Cancer Date: 2018-05-31 Impact factor: 3.603
Authors: Rania Abasaeed; Susan E Coldwell; Michele E Lloid; Sohaib H Soliman; Paula C Macris; Mark M Schubert Journal: Support Care Cancer Date: 2018-04-27 Impact factor: 3.603